Sort
21,453 grants matching “tuberculosis”
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,712Marvin J Miller · University Of Notre Dame · R37 · FY2022 · AI
Role of Tuberculosinyl Metabolites in M. Tuberculosis Virulence
$562,684David Branch Moody · Brigham And Women'S Hospital · R01 · FY2015 · AI
Antimicrobial Resistance in Bacteria
$562,497Stanley N Cohen · Stanford University · R01 · FY2010 · AI
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,443Marvin J Miller · University Of Notre Dame · R37 · FY2023 · AI
Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in Brazil
$562,393Jonathan E Golub · Johns Hopkins University · R01 · FY2017 · AI
Novel Murine Studies for Optimizing Effective Short-Course TB Therapy
$562,357Arnold Louie · University Of Florida · P01 · FY2020 · AI
Biocomputation across distributed private datasets to enhance drug discovery
$562,173Sean Ekins · Collaborative Drug Discovery, Inc. · R44 · FY2014 · TR
NUTRITION, IMMUNOLOGY, AND EPIDEMIOLOGY OF TB
$562,158Harvard University (Sch Of Public Hlth) · U01 · FY2002 · AI
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,125Marvin J Miller · University Of Notre Dame · R37 · FY2024 · AI
Defining the roles of small KH-domain RNA binding proteins in mycobacteria
$562,123Scarlet Sara Shell · Worcester Polytechnic Institute · R15 · FY2025 · GM
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,117Marvin J Miller · University Of Notre Dame · R37 · FY2025 · AI
Understanding and addressing geographic barriers to accessing TB services in a high-burden urban setting
$562,047Helen E. Jenkins · Boston University Medical Campus · R01 · FY2025 · AI
Evaluating health and economic effects of targeted strategies in TB/HIV
$562,005Theodore H Cohen · Yale University · R01 · FY2017 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$561,929Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Robust Genetic Switches for Mycobacteria
$561,891Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R56 · FY2011 · AI
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
$561,889William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R24 · FY2017 · AI
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations
$561,785David Wesley Dowdy · Johns Hopkins University · R01 · FY2021 · AI
PRODUCT DEVELOPMENT OF A MEMBRANE TETRASPANIN VACCINE AGAINST SCHISTOSOMIASIS
$561,750Peter J Hotez · Albert B. Sabin Vaccine Institute · R56 · FY2011 · AI
T regulatory cells and immunity in tuberculosis
$561,642Kevin B Urdahl · Seattle Biomedical Research Institute · R01 · FY2015 · AI
Escape of Mycobacterium tuberculosis from the macrophage is regulated by eicosano
$561,638Heinz Gernot Remold · Brigham And Women'S Hospital · R56 · FY2009 · AI
Autophagy-based HDT for tuberculosis
$561,389Vojo P Deretic · University Of New Mexico Health Scis Ctr · UH2 · FY2016 · AI
Sex, HIV, and Air Pollution Effects on Post-TB Lung Disease (SHAPE PTLD)
$561,226Laurence Huang · University Of California, San Francisco · R01 · FY2025 · HL
High Dose Oral Rifampicin to Improve Survival from Adult Tuberculous Meningitis: a pharmacokinetic substudy (HARVEST-PK)
$561,023Lindsey Te Brake · Stichting Radboud Universitair Medisch Centrum I.O. · R01 · FY2025 · AI
High Dose Oral Rifampicin to Improve Survival from Adult Tuberculous Meningitis: a pharmacokinetic substudy (HARVEST-PK)
$561,021Lindsey Te Brake · Stichting Radboud Universitair Medisch Centrum I.O. · R01 · FY2024 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$560,663Iram Bakhtawar · Arkansas State Department Of Health · U52 · FY2008 · PS